CLINICAL_TRIALS
trial_result
· 2017-05-18
Clinical Trial Update: A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g) [Phase 2]
Summary
Phase 2 study of PRO95780 in previously untreated, advanced-stage non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED